logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yuri Ozaki

aichi cancer center
H指数:10
被引数:498

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM) (Aug, 10.1007/s12282-024-01614-1, 2024)
BREAST CANCER
IF2.9
2024-09-200
OAAI
Nakayama, Takahiro; Niikura, Naoki; Yamanaka, Takashi; Yamamoto, Mitsugu; Matsuura, Kazuo; Inoue, Kenichi; Takahara, Sachiko; Nomura, Hironori; Kita, Shosuke; Yamaguchi, Miki; Aruga, Tomoyuki; Shibata, Nobuhiro; Shimomura, Akihiko; Ozaki, Yuri; Sakai, Shuji; Takiguchi, Daisuke; Takata, Takehiko; Bastanfard, Armin; Shiosakai, Kazuhito; Tsurutani, Junji
Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM)

曲妥珠单抗deruxtecan治疗脑和/或软脑膜转移的HER2-positive乳腺癌患者: 使用多中心回顾性研究 (roset-bm) 数据进行的更新的总生存分析

BREAST CANCER
IF2.9
2024-08-125
OAAI
Nakayama, Takahiro; Niikura, Naoki; Yamanaka, Takashi; Yamamoto, Mitsugu; Matsuura, Kazuo; Inoue, Kenichi; Takahara, Sachiko; Nomura, Hironori; Kita, Shosuke; Yamaguchi, Miki; Aruga, Tomoyuki; Shibata, Nobuhiro; Shimomura, Akihiko; Ozaki, Yuri; Sakai, Shuji; Takiguchi, Daisuke; Takata, Takehiko; Bastanfard, Armin; Shiosakai, Kazuhito; Tsurutani, Junji
Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational study

曲妥珠单抗后deruxtecan治疗对不可切除或转移性乳腺癌患者的临床益处: 一项单机构回顾性观察研究

BREAST CANCER RESEARCH AND TREATMENT
IF3
2024-05-260
PRE
Isogai, Ayaka; Nozawa, Kazuki; Nakakami, Akira; Komaki, Rie; Ozaki, Yuri; Endo, Yuka; Kataoka, Ayumi; Kotani, Haruru; Yoshimura, Akiyo; Hattori, Masaya; Sawaki, Masataka; Iwata, Hiroji
Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Yamanaka, Takashi; Niikura, Naoki; Nakayama, Takahiro; Yamamoto, Mitsugu; Matsuura, Kazuo; Inoue, Kenichi; Takahara, Sachiko; Nomura, Hironori; Kita, Shosuke; Yamaguchi, Miki; Aruga, Tomoyuki; Shibata, Nobuhiro; Shimomura, Akihiko; Ozaki, Yuri; Sakai, Shuji; Takiguchi, Daisuke; Takata, Takehiko; Bastanfard, Armin; Shiosakai, Kazuhito; Tsurutani, Junji
Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM)
NPJ BREAST CANCER
IF7.6
2023-10-1131
OAAI
Niikura, Naoki; Yamanaka, Takashi; Nomura, Hironori; Shiraishi, Kazuhiro; Kusama, Hiroki; Yamamoto, Mitsugu; Matsuura, Kazuo; Inoue, Kenichi; Takahara, Sachiko; Kita, Shosuke; Yamaguchi, Miki; Aruga, Tomoyuki; Shibata, Nobuhiro; Shimomura, Akihiko; Ozaki, Yuri; Sakai, Shuji; Kiga, Yoko; Izutani, Tadahiro; Shiosakai, Kazuhito; Tsurutani, Junji
Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: A multicenter retrospective study (ROSET-BM study)
CANCER RESEARCH
IF16.6
2023-03-017
PRE
Yamanaka, Takashi; Niikura, Naoki; Nomura, Hironori; Kusama, Hiroki; Yamamoto, Mitsugu; Matsuura, Kazuo; Inoue, Kenichi; Takahara, Sachiko; Kita, Shosuke; Yamaguchi, Miki; Aruga, Tomoyuki; Shibata, Nobuhiro; Shimomura, Akihiko; Ozaki, Yuri; Shiraishi, Kazuhiro; Sakai, Shuji; Kiga, Yoko; Izutani, Tadahiro; Shiosakai, Kazuhito; Tsurutani, Junji
The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status

乳腺癌中HER2低表达的频率以及通过HR状态比较HER2-low和HER2-negative乳腺癌患者的预后

BREAST CANCER
IF2.9
2021-10-07133
OA
Horisawa, Nanae; Adachi, Yayoi; Takatsuka, Daiki; Nozawa, Kazuki; Endo, Yuka; Ozaki, Yuri; Sugino, Kayoko; Kataoka, Ayumi; Kotani, Haruru; Yoshimura, Akiyo; Hattori, Masaya; Sawaki, Masataka; Iwata, Hiroji

研究方向

暂未获取到该数据
M
Masataka Sawaki
H 指数:25论文数:227被引数:2,192
H
Haruru Kotani
H 指数:19论文数:89被引数:5,984
A
Ayumi Kataoka
H 指数:10论文数:62被引数:476
H
Hiroji Iwata
H 指数:89论文数:843被引数:5.6万
N
Nanae Horisawa
H 指数:10论文数:39被引数:459
A
Akiyo Yoshimura
H 指数:20论文数:101被引数:1,693
Y
Yuka Endo
H 指数:23论文数:156被引数:1,902
M
Masaya Hattori
H 指数:30论文数:233被引数:9,499
Y
Yayoi Adachi
H 指数:15论文数:73被引数:776
K
Kayoko Sugino
H 指数:9论文数:52被引数:436